StockSelector.com
  Research, Select, & Monitor Saturday, April 20, 2019 4:28:19 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ligand Pharmaceuticals, Inc.$122.11$2.221.85%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ligand Pharmaceuticals, Inc. has an overall rank of 626 out of 6824 stocks based on 11 positive rankings and 9 negative rankings.

Positive Rankings
Historic EPS Growth
Ligand Pharmaceuticals rank is 54
Target Prices
The average analysts' target price is $254.00 for Ligand Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Ligand Pharmaceuticals is ranked 67.
Highest Cash Growth
Ligand Pharmaceuticals rank is 101
Highest Net Margin
Ligand Pharmaceuticals rank is 107
Positive Stoch Cross
Ligand Pharmaceuticals rank is 113
Positive Guidance
Within the past 90 days Ligand Pharmaceuticals has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Historic Revenue Growth
Ligand Pharmaceuticals rank is 282
SSValue
The StockSelector Value for Ligand Pharmaceuticals is $329.84. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ligand Pharmaceuticals is ranked 445.
Highest ROE
Ligand Pharmaceuticals rank is 469
Highest ROA
Ligand Pharmaceuticals rank is 471
Up EPS Surprise
Ligand Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative Revenue Estimate
Ligand Pharmaceuticals rank is 35
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Ligand Pharmaceuticals is ranked 365.
Price-to-Sales
Ligand Pharmaceuticals rank is 479
90 Day Loss
Ligand Pharmaceuticals rank is 664
Price-to-Book
Ligand Pharmaceuticals rank is 957
10 Day Loss
Ligand Pharmaceuticals rank is 1057
High Put/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 0.77 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 1234.
High vPut/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 0.62 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 1757.
Debt-to-Equity
Ligand Pharmaceuticals rank is 2206







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.